• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

血清 FGF-23 与 PTH 在甲状旁腺功能减退症患者肾磷排泄中的相互作用:一项病例对照研究。

Interaction between serum FGF-23 and PTH in renal phosphate excretion, a case-control study in hypoparathyroid patients.

机构信息

Shiraz Endocrinology and Metabolism Research Center, Shiraz University of Medical Sciences, P.O. Box: 71345-1744, Shiraz, Iran.

出版信息

BMC Nephrol. 2020 May 12;21(1):176. doi: 10.1186/s12882-020-01826-5.

DOI:10.1186/s12882-020-01826-5
PMID:32398014
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7218502/
Abstract

BACKGROUND

phosphate homeostasis is mediated through complex counter regulatory feed-back balance between parathyroid hormone, FGF-23 and 1,25(OH)2D. Both parathyroid hormone and FGF-23 regulate proximal tubular phosphate excretion through signaling on sodium- phosphate cotransporters II and II. However, the interaction between these hormones on phosphate excretion is not clearly understood. We performed the present study to evaluate whether the existence of sufficient parathyroid hormone is necessary for full phosphaturic function of FGF-23 or not.

METHODS

In this case-control study, 19 patients with hypoparathyroidism and their age- and gender-matched normal population were enrolled. Serum calcium, phosphate, alkaline phosphatase,parathyroid hormone, FGF-23, 25(OH)D, 1,25(OH)2D and Fractional excretion of phosphorous were assessed and compared between the two groups, using SPSS software.

RESULTS

The mean serum calcium and parathyroid hormone level was significantly lower in hypoparathyroid patients in comparison with the control group (P < 0.001 and P < 0.001, respectively). We found high serum level of phosphate and FGF-23 in hypoparathyroid patients compared to the control group (P < 0.001 and P < 0.001, respectively). However, there was no significant difference in Fractional excretion of phosphorous or 1,25OH2D level between the two groups. There was a positive correlation between serum FGF-23 and Fractional excretion of phosphorous just in the normal individuals (P < 0.001, r = 0.79).

CONCLUSIONS

Although the FGF-23 is a main regulator of urinary phosphate excretion but the existence of sufficient parathyroid hormone is necessary for the full phosphaturic effect of FGF-23.

摘要

背景

磷稳态是通过甲状旁腺激素、FGF-23 和 1,25(OH)2D 之间复杂的反向调节反馈平衡来介导的。甲状旁腺激素和 FGF-23 均通过对钠-磷共转运蛋白 II 和 II 的信号转导来调节近端肾小管磷酸盐排泄。然而,这些激素之间在磷酸盐排泄方面的相互作用尚不清楚。我们进行了本研究,以评估甲状旁腺激素的存在是否对 FGF-23 的完全排磷功能是必需的。

方法

在这项病例对照研究中,纳入了 19 例甲状旁腺功能减退症患者及其年龄和性别匹配的正常人群。使用 SPSS 软件评估和比较两组患者的血清钙、磷、碱性磷酸酶、甲状旁腺激素、FGF-23、25(OH)D、1,25(OH)2D 和磷的分数排泄。

结果

与对照组相比,甲状旁腺功能减退症患者的血清钙和甲状旁腺激素水平显著降低(P<0.001 和 P<0.001)。与对照组相比,甲状旁腺功能减退症患者的血清磷和 FGF-23 水平较高(P<0.001 和 P<0.001)。然而,两组之间的磷的分数排泄或 1,25OH2D 水平没有显著差异。仅在正常个体中,血清 FGF-23 与磷的分数排泄之间存在正相关(P<0.001,r=0.79)。

结论

虽然 FGF-23 是尿磷排泄的主要调节因子,但甲状旁腺激素的存在是 FGF-23 完全排磷作用所必需的。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d8d3/7218502/93665a59ebad/12882_2020_1826_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d8d3/7218502/93665a59ebad/12882_2020_1826_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d8d3/7218502/93665a59ebad/12882_2020_1826_Fig1_HTML.jpg

相似文献

1
Interaction between serum FGF-23 and PTH in renal phosphate excretion, a case-control study in hypoparathyroid patients.血清 FGF-23 与 PTH 在甲状旁腺功能减退症患者肾磷排泄中的相互作用:一项病例对照研究。
BMC Nephrol. 2020 May 12;21(1):176. doi: 10.1186/s12882-020-01826-5.
2
Association of vitamin D and FGF23 with serum ferritin in hypoparathyroid thalassemia: a case control study.甲状旁腺功能减退性地中海贫血患者血清铁蛋白与维生素 D 和 FGF23 的相关性:病例对照研究。
BMC Nephrol. 2020 Nov 16;21(1):482. doi: 10.1186/s12882-020-02101-3.
3
Effect of vitamin D treatment in hypoparathyroid patients: a study on calcium, phosphate and magnesium homeostasis.维生素D治疗对甲状旁腺功能减退患者的影响:一项关于钙、磷和镁稳态的研究。
Eur J Endocrinol. 1997 Jan;136(1):52-60. doi: 10.1530/eje.0.1360052.
4
Fibroblast growth factor-23 in early chronic kidney disease: additional support in favor of a phosphate-centric paradigm for the pathogenesis of secondary hyperparathyroidism.成纤维细胞生长因子 23 在慢性肾脏病早期:对继发性甲状旁腺功能亢进发病机制的磷中心假说提供更多支持。
Clin J Am Soc Nephrol. 2010 Jul;5(7):1268-76. doi: 10.2215/CJN.08241109. Epub 2010 May 6.
5
Cinacalcet in the management of tumor-induced osteomalacia.西那卡塞在肿瘤诱导性骨软化症治疗中的应用
J Bone Miner Res. 2007 Jun;22(6):931-7. doi: 10.1359/jbmr.070304.
6
Acid Load and Phosphorus Homeostasis in CKD.慢性肾脏病中的酸负荷与磷稳态
Am J Kidney Dis. 2017 Oct;70(4):541-550. doi: 10.1053/j.ajkd.2017.04.022. Epub 2017 Jun 21.
7
Under-recognized Hypoparathyroidism in Thalassemia.地中海贫血中未被充分认识的甲状旁腺功能减退症
J Clin Res Pediatr Endocrinol. 2018 Nov 29;10(4):324-330. doi: 10.4274/jcrpe.0020. Epub 2018 May 4.
8
Activation of FGF-23 mediated vitamin D degradative pathways by cholecalciferol.胆钙化醇对成纤维细胞生长因子23介导的维生素D降解途径的激活作用。
J Clin Endocrinol Metab. 2014 Oct;99(10):E1830-7. doi: 10.1210/jc.2014-1308. Epub 2014 Jun 24.
9
Mechanisms of renal phosphate loss in liver resection-associated hypophosphatemia.肝切除相关低磷血症中肾脏磷流失的机制。
Ann Surg. 2009 May;249(5):824-7. doi: 10.1097/SLA.0b013e3181a3e562.
10
The effect of an oral sodium phosphate load on parathyroid hormone and fibroblast growth factor 23 secretion in normo- and hypercalciuric stone-forming patients.口服磷酸钠负荷对正常钙尿和高钙尿结石形成患者甲状旁腺激素和成纤维细胞生长因子 23 分泌的影响。
Clin Nutr. 2020 Dec;39(12):3804-3812. doi: 10.1016/j.clnu.2020.04.020. Epub 2020 Apr 21.

引用本文的文献

1
Impaired intestinal calcium absorption and osteopathy in ICR/Mlac-hydro mice with hypoparathyroidism and severe hydronephrosis.甲状旁腺功能减退和严重肾积水的ICR/Mlac-hydro小鼠肠道钙吸收受损与骨病
Sci Rep. 2025 Jul 1;15(1):22103. doi: 10.1038/s41598-025-06485-w.
2
Hypoparathyroidism in adults with iron overload diseases (IOD): evidence of a subclinical phenotype.铁过载疾病(IOD)成人患者的甲状旁腺功能减退:亚临床表型的证据
Endocrine. 2025 Mar;87(3):1257-1266. doi: 10.1007/s12020-024-04124-4. Epub 2024 Dec 4.
3
Non-Classical Effects of FGF23: Molecular and Clinical Features.

本文引用的文献

1
Role of the putative PKC phosphorylation sites of the type IIc sodium-dependent phosphate transporter in parathyroid hormone regulation.Ⅱc 型钠依赖性磷酸盐转运体假定蛋白激酶 C 磷酸化位点在甲状旁腺激素调节中的作用。
Clin Exp Nephrol. 2019 Jul;23(7):898-907. doi: 10.1007/s10157-019-01725-6. Epub 2019 Mar 21.
2
Analysis of opossum kidney NaPi-IIc sodium-dependent phosphate transporter to understand Pi handling in human kidney.分析负鼠肾钠依赖性磷酸盐转运体NaPi-IIc以了解人类肾脏中的磷处理情况。
Clin Exp Nephrol. 2019 Mar;23(3):313-324. doi: 10.1007/s10157-018-1653-4. Epub 2018 Oct 13.
3
Review of Hypoparathyroidism.
FGF23 的非经典作用:分子和临床特征。
Int J Mol Sci. 2024 Apr 30;25(9):4875. doi: 10.3390/ijms25094875.
4
Calcium, Phosphorus and Magnesium Abnormalities Associated with COVID-19 Infection, and Beyond.与新型冠状病毒肺炎感染及其他情况相关的钙、磷和镁异常
Biomedicines. 2023 Aug 23;11(9):2362. doi: 10.3390/biomedicines11092362.
5
Chronic hypoparathyroidism is associated with increased cortical bone density evaluated using high-resolution peripheral quantitative computed tomography.慢性甲状旁腺功能减退症与使用高分辨率外周定量计算机断层扫描评估的皮质骨密度增加有关。
Endocrine. 2023 Dec;82(3):673-680. doi: 10.1007/s12020-023-03495-4. Epub 2023 Aug 25.
6
Effects of Burosumab Treatment on Two Siblings with X-Linked Hypophosphatemia. Case Report and Literature Review.布罗索尤单抗治疗 X 连锁低磷血症两兄妹的疗效:病例报告及文献复习。
Genes (Basel). 2022 Aug 4;13(8):1392. doi: 10.3390/genes13081392.
7
New concepts in regulation and function of the FGF23.成纤维细胞生长因子 23 的调控与功能的新概念。
Clin Exp Med. 2023 Aug;23(4):1055-1066. doi: 10.1007/s10238-022-00844-x. Epub 2022 Jun 16.
8
The Role of Fibroblast Growth Factor 19 Subfamily in Different Populations Suffering From Osteoporosis.成纤维细胞生长因子 19 亚家族在不同骨质疏松症人群中的作用。
Front Endocrinol (Lausanne). 2022 Apr 28;13:830022. doi: 10.3389/fendo.2022.830022. eCollection 2022.
9
Use of Teriparatide in Hyperphosphatemic Familial Tumor Calcinosis: Evaluating the Interaction Between FGF23 and PTH on the Phosphaturic Effect.特立帕肽在高磷血症家族性肿瘤性钙化症中的应用:评估 FGF23 和 PTH 对磷排泄作用的相互影响。
Calcif Tissue Int. 2022 Jul;111(1):102-106. doi: 10.1007/s00223-022-00969-x. Epub 2022 Mar 25.
10
Environmental Factors That Affect Parathyroid Hormone and Calcitonin Levels.影响甲状旁腺激素和降钙素水平的环境因素。
Int J Mol Sci. 2021 Dec 21;23(1):44. doi: 10.3390/ijms23010044.
甲状旁腺功能减退症综述
Front Endocrinol (Lausanne). 2017 Jan 16;7:172. doi: 10.3389/fendo.2016.00172. eCollection 2016.
4
Control of phosphate balance by the kidney and intestine.肾脏和肠道对磷酸盐平衡的调节
Clin Exp Nephrol. 2017 Mar;21(Suppl 1):21-26. doi: 10.1007/s10157-016-1359-4. Epub 2016 Nov 30.
5
The FGF23 and Klotho system beyond mineral metabolism.超越矿物质代谢的成纤维细胞生长因子23(FGF23)和α-klotho系统
Clin Exp Nephrol. 2017 Mar;21(Suppl 1):64-69. doi: 10.1007/s10157-016-1357-6. Epub 2016 Nov 12.
6
Effects of parathyroid hormone rhPTH(1-84) on phosphate homeostasis and vitamin D metabolism in hypoparathyroidism: REPLACE phase 3 study.重组人甲状旁腺激素rhPTH(1-84)对甲状旁腺功能减退症患者磷稳态及维生素D代谢的影响:REPLACE 3期研究
Endocrine. 2017 Jan;55(1):273-282. doi: 10.1007/s12020-016-1141-0. Epub 2016 Oct 12.
7
Fgf23 and parathyroid hormone signaling interact in kidney and bone.成纤维细胞生长因子23(Fgf23)与甲状旁腺激素信号在肾脏和骨骼中相互作用。
Mol Cell Endocrinol. 2016 Nov 15;436:224-39. doi: 10.1016/j.mce.2016.07.035. Epub 2016 Aug 4.
8
Phosphate and FGF-23.磷酸盐和 FGF-23。
Kidney Int. 2011 Apr;79121:S24-7. doi: 10.1038/ki.2011.27.
9
Pharmacokinetics and pharmacodynamics of subcutaneous recombinant parathyroid hormone (1-84) in patients with hypoparathyroidism: an open-label, single-dose, phase I study.皮下注射重组甲状旁腺激素(1-84)在甲状旁腺功能减退患者中的药代动力学和药效学:一项开放标签、单剂量、I期研究。
Clin Ther. 2014 May;36(5):722-36. doi: 10.1016/j.clinthera.2014.04.001. Epub 2014 May 5.
10
The importance of klotho in phosphate metabolism and kidney disease.klotho在磷酸盐代谢和肾脏疾病中的重要性。
Nephrology (Carlton). 2014 Aug;19(8):439-49. doi: 10.1111/nep.12268.